pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,150 catalysts · 4,876 phase readout · 2,332 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,332
  • earnings286
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
  • phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06159673: ACP-204 in Adults With Alzheimer's Disease Psychosis

    Sponsor: ACADIA Pharmaceuticals Inc.. Phase: PHASE2. Conditions: Alzheimer's Disease Psychosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07601373: Artificial Intelligence in Perioperative Nursing

    Sponsor: Alexandria University. Phase: . Conditions: Artificial Intelligence (AI), Perioperative Nursing, Surgical Care, Nursing Informatics

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06216769: Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07698470: Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use

    Sponsor: University of Southern California. Phase: NA. Conditions: Nicotine Dependence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07614373: Virtual Reality-based Mindfulness Training for Mental Health After Stroke

    Sponsor: Nicolas Nicastro. Phase: NA. Conditions: Stroke (Subacute)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07684573: Scar Gel Product Family Clinical Investigation

    Sponsor: Hanson Medical, Inc.. Phase: . Conditions: Hypertrophic Scars, Keloids

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07317869: Impact Evaluation of the Therapeutic Initiative's Prescribing Portrait and Therapeutics Letter on Opioid Use by Dentists

    Sponsor: University of British Columbia. Phase: NA. Conditions: Clinical Audit, Quality Improvement, Opioid, Dentistry

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT07524283: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03794583: Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

    Sponsor: United Therapeutics. Phase: PHASE3. Conditions: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07680283: Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

    Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Crohn's Disease (CD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05615441: Effect of Nociception Level Monitoring During Remimazolam-based Total Intravenous Anesthesia on Intraoperative Opioid Requirements and Postoperative Pain

    Sponsor: Yonsei University. Phase: NA. Conditions: Adult Patients Aged 19-64, Scheduled for Elective Arthroscopic Knee Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07366905: Clinical Observation of Bupivacaine Liposome for Lower Extremity Nerve Block

    Sponsor: Hainan Medical College. Phase: PHASE2. Conditions: Patients Eligible for Elective Lower Extremity Femoral Nerve Surgery, Knee Arthroscopic Surgery

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07448454: Role of Vessel Wall MRI in Differentiaition Between Intracranial Atherosclerotic Disease and Vasculitis as Causes of Ischemic Stroke

    Sponsor: Assiut University. Phase: NA. Conditions: Intracranial Atherosclerotic Disease (ICAD) and Vasculitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06999005: Longitudinal Evaluation of Minimally Invasive Protocols for Dental Caries in Brazilian Schoolchildren

    Sponsor: University of Nove de Julho. Phase: NA. Conditions: Dental Caries

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07593105: Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes

    Sponsor: Ain Shams University. Phase: NA. Conditions: Type 1 Diabetes, Nutrition

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07165366: Clinical Evaluation of Enamel Microhardness Using Tooth Whitening Agents

    Sponsor: Ultradent Products, Inc.. Phase: NA. Conditions: Dental Atraumatic Restorative Treatment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05633056: An Adaptive Randomized Controlled Trial

    Sponsor: Columbia University. Phase: NA. Conditions: Multi Drug Resistant Tuberculosis, HIV Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06769256: Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden

    Sponsor: Henan Institute of Cardiovascular Epidemiology. Phase: PHASE4. Conditions: ST-segment Elevation Myocardial Infarction (STEMI)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05406622: MOTIV BTK Randomized Controlled Trial

    Sponsor: REVA Medical, Inc.. Phase: NA. Conditions: Critical Limb Ischemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06991751: A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...

    Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Cardiometabolic Risk Factors, Mental Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06814951: Acute Effect of the Thoraco-abdominal Rebalance Method Postoperative Cardiac Surgery

    Sponsor: Instituto de Cardiologia do Rio Grande do Sul. Phase: NA. Conditions: Respiratory Complications, Diaphragmatic Excursion, Pulmonary Spirometry

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06918431: Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07433231: Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients

    Sponsor: Ayfer Kaya Gök. Phase: NA. Conditions: Anesthesia Emergence Delirium, Adenotonsillar Hypertrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07611331: Single-Layer Versus Double-Layer Uterine Closure After Primary Cesarean Section

    Sponsor: Hédi Chaker Hospital. Phase: NA. Conditions: Cesarean Scar Defect (Isthmococele), Pelvic Pain, Spotting, Amenorrhea Secondary, Metrorrhagia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07089953: Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Communication Skills, Professionalism, Randomized Controlled Trial, Perception

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03083353: Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

    Sponsor: Jasper A. Smits. Phase: EARLY_PHASE1. Conditions: Nicotine Dependence, Smoking, Cigarette, Smoking Cessation, Smoking Behaviors, Smoking Reduction, Craving

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05093153: Spanish Registry of Patients With IgM Monoclonal Gammopathies

    Sponsor: Fundación Española de Hematología y Hemoterapía. Phase: . Conditions: Waldenstrom Macroglobulinemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05650853: Exploration of eJaculatory Anatomy Concept Study (EJAC Study)

    Sponsor: Clinique Pasteur. Phase: NA. Conditions: Ejaculatory Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07588737: Multimodal AI-Guided Recovery Management After Lung Cancer Surgery

    Sponsor: The First Affiliated Hospital of Guangzhou Medical University. Phase: NA. Conditions: Postoperative Care, Rehabilitation, Artificial Intelligence (Al), Randomized Controlled Trial (RCT)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07530237: Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery

    Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Phase: . Conditions: Intraoperative Bleeding in Lumbar Spine Surgery, Postoperative Pain in Lumbar Spine Surgery

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07587437: Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery

    Sponsor: Jerry Dang. Phase: NA. Conditions: Obesity, Bariatric Surgery Candidate, Hypertension, Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05751837: Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors

    Sponsor: Patrick Wagner, MD, FACS. Phase: PHASE1. Conditions: Abdominal Cancer, Malignancy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05895929: The Role of IL5 in Epithelial Cell Integrity

    Sponsor: Johns Hopkins University. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07582731: A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

    Sponsor: Jie Liang. Phase: NA. Conditions: Inflammatory Bowel Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06118931: Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

    Sponsor: University of Toronto. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Obesity, Prediabetic State, Hyperglycemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07470502: MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

    Sponsor: Meyer Children's Hospital IRCCS. Phase: NA. Conditions: IBD (Inflammatory Bowel Disease)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04368702: CONFIRM: Magnetic Resonance Guided Radiation Therapy

    Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Mantle Cell Lymphoma, Larynx Cancer, Bladder Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379502: Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

    Sponsor: CMH Kharian Medical College. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491445: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

    Sponsor: Revolution Medicines, Inc.. Phase: PHASE3. Conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06441435: The Effect of AC-134 in Chronic Kidney Diseases

    Sponsor: Taichung Veterans General Hospital. Phase: NA. Conditions: Nephrology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06835725: Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

    Sponsor: British Columbia Cancer Agency. Phase: PHASE2. Conditions: Prostate CA

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05739825: Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Clostridioides Difficile Infection Recurrence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07215325: Got Doxy- 'Flipping the Script' on STI PEP

    Sponsor: Emory University. Phase: PHASE4. Conditions: Sexually Transmitted Infections (STI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06044025: A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

    Sponsor: University of Arkansas. Phase: PHASE1. Conditions: Castration Sensitive Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07471425: Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

    Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Neuroendocrine (NE) Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06800508: Primary and Secondary Stability of a One-Piece Compressive Implant System

    Sponsor: University of Sulaimani. Phase: . Conditions: Dental Implant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01617408: Brain Stimulation and Vision Testing

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: fMRI, Dorsal Pathway, Ventral Pathway

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07680725: The Effect of Bottle PEP Exercise on Expiratory Muscle Thickness, Strength, and Balance Parameters in Parkinson's Disease Patients

    Sponsor: Marmara University. Phase: . Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06532240: Methylene Blue for the Treatment of Septic Shock

    Sponsor: Northern Jiangsu People's Hospital. Phase: PHASE3. Conditions: Septic Shock

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07572240: A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

    Sponsor: Rousselot BVBA. Phase: NA. Conditions: Healthy, Stress

    full page →ctgov ↗
    ← prev
    page 86 of 103
    next →